Literature DB >> 1396267

Composition of premature breast-milk during lactation: constant digestible protein content (as in full term milk).

R J Beijers1, F V Graaf, A Schaafsma, A D Siemensma.   

Abstract

There is much discussion about the protein requirements of (very) preterm infants. The protein content of breast milk plays an important role in this discussion. For this reason, we took a close look at the protein content and its composition in premature breast milk. Complete 24 h expressions-were examined using the Kjedahl method, GPC, SDS-PAGGE and nephelometric detection of sIgA. Colostrum of premature breast milk contains a large amount of undigestible proteins, up to 70% of true protein, which decreases to 20-40% in transitory and mature preterm milk. The NPN fraction of mature preterm breast milk was, dependent on the degree of prematurity 20-25%; increasing during lactation from about 18% to 22-26%. This means that, depending on the lactation period only 30-60% of the total protein content of breast milk is available for body protein synthesis. In absolute amounts, digestible protein is reasonably stable during lactation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1396267     DOI: 10.1016/0378-3782(92)90191-i

Source DB:  PubMed          Journal:  Early Hum Dev        ISSN: 0378-3782            Impact factor:   2.079


  3 in total

Review 1.  Variation in the Protein Composition of Human Milk during Extended Lactation: A Narrative Review.

Authors:  Sergio Verd; Gemma Ginovart; Javier Calvo; Jaume Ponce-Taylor; Antoni Gaya
Journal:  Nutrients       Date:  2018-08-20       Impact factor: 5.717

Review 2.  Amino acid profiles in term and preterm human milk through lactation: a systematic review.

Authors:  Zhiying Zhang; Alicia S Adelman; Deshanie Rai; Julia Boettcher; Bo Lőnnerdal
Journal:  Nutrients       Date:  2013-11-26       Impact factor: 5.717

Review 3.  A systematic review and meta-analysis of the nutrient content of preterm and term breast milk.

Authors:  Dominica A Gidrewicz; Tanis R Fenton
Journal:  BMC Pediatr       Date:  2014-08-30       Impact factor: 2.125

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.